Structural Genomics Consortium and Division of Chemical Biology and Medicinal Chemistry, UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599, United States.
Department of Pharmacology, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599, United States.
J Med Chem. 2021 Aug 12;64(15):10849-10877. doi: 10.1021/acs.jmedchem.0c02274. Epub 2021 Jul 15.
CAMKK2 is a serine/threonine kinase and an activator of AMPK whose dysregulation is linked with multiple diseases. Unfortunately, STO-609, the tool inhibitor commonly used to probe CAMKK2 signaling, has limitations. To identify promising scaffolds as starting points for the development of high-quality CAMKK2 chemical probes, we utilized a hinge-binding scaffold hopping strategy to design new CAMKK2 inhibitors. Starting from the potent but promiscuous disubstituted 7-azaindole GSK650934, a total of 32 compounds, composed of single-ring, 5,6-, and 6,6-fused heteroaromatic cores, were synthesized. The compound set was specifically designed to probe interactions with the kinase hinge-binding residues. Compared to GSK650394 and STO-609, 13 compounds displayed similar or better CAMKK2 inhibitory potency , while compounds and had improved selectivity for CAMKK2 across the kinome. Our systematic survey of hinge-binding chemotypes identified several potent and selective inhibitors of CAMKK2 to serve as starting points for medicinal chemistry programs.
CAMKK2 是一种丝氨酸/苏氨酸激酶,也是 AMPK 的激活剂,其失调与多种疾病有关。不幸的是,STO-609 是常用的探测 CAMKK2 信号的工具抑制剂,具有局限性。为了确定有前途的支架作为开发高质量 CAMKK2 化学探针的起点,我们利用铰链结合支架跳跃策略来设计新的 CAMKK2 抑制剂。从强效但有广谱活性的双取代 7-氮茚 GSK650934 出发,共合成了 32 种化合物,由单环、5,6-和 6,6-稠合杂芳烃核心组成。该化合物集专门设计用于探测与激酶铰链结合残基的相互作用。与 GSK650394 和 STO-609 相比,有 13 种化合物表现出相似或更好的 CAMKK2 抑制活性,而化合物 和 对激酶组具有改善的 CAMKK2 选择性。我们对铰链结合化学型的系统调查确定了几种强效和选择性的 CAMKK2 抑制剂,可作为药物化学项目的起点。